Keywords: gsk, sells, part, its, quest, sake, 256m

GSK sells part of its Quest sake for $256M

Article | 30 March 2009

Print This

UK pharmaceutical giant GlaxoSmithKline says that it has sold 5,749,157 shares of common stock in Quest Diagnostics for a total of $256.0 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in